Summary
Glycogen storage disease type III (GSD III; OMIM 232400) is an autosomal recessive deficiency of the glycogen debrancher enzyme, amylo-1,6-glucosidase (EC 3.2.1.33). Patients with other hepatic glycogenoses are known to have reduced bone mineral content (BMC) and to be at consequent risk of fractures. They have key metabolic differences from GSD III patients, however. This study examines bone density and metabolism in 15 GSD III patients (6 female) from childhood to adulthood (aged 10–34 years). The results demonstrate that patients with GSD III have low bone mass at all skeletal sites compared with healthy individuals of the same age and sex, with a significant proportion (40–64%) having BMD > 2 standard deviations below the mean for whole body and lumbar spine. The deficiency seems to be attributable to a mixed muscle andbone deficit. Lower bone mass was found at all sites for GSD IIIa patients (combined liver and muscle defect) compared with GSD IIIb patients (liver only defect). Conclusion: Patients with GSD III have significantly abnormal bone mass, placing them at increased risk of potential fracture. The underlying mechanism is probably multifactorial with contributions from abnormal muscle physiology, abnormal metabolic milieu and altered nutrition affecting micronutrient intake. Therapies need to address all these factors to be successful.
Similar content being viewed by others
References
Bao Y, Yang BZ, Dawson TL, Chen YT (1997) Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms. Gene 197: 389–398.
Cabrera-Abreu J, Crabtree NJ, Elias E, Fraser W, Cramb R, Alger S (2004) Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX. J Inherit Metab Dis 27: 1–9.
Cejudo P, Bautista J, Montemayor T, et al (2005) Exercise training in mitochondrial myopathy: a randomized controlled trial. Muscle Nerve 32: 342–350.
Crabtree NJ, Kibirige MS, Fordham JN et al (2004) The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone 35: 965–972.
Fewtrell MS, Prentice A, Jones SC, Lunt M, Cole TJ, Lucas A (1999) Bone mineralisation and turnover in preterm infants at 8–12 years of age; the effects of early diet. J Bone Miner Res 14: 810–820.
Hogler W, Briody JN, Woodhead HJ, Chan A, Cowell CT (2003) Importance of lean mass in the interpretation of total body densitometry in children and adolescents. J Pediatr 143: 81–88.
Hurley BF, Roth SM (2000) Strength training in the elderly: effects on risk factors for age-related diseases. Sports Med 30: 249–268.
Kalkwarf HJ, Khoury JC, Lanphear BP (2003) Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr 77: 257–265.
Lee PJ, Patel JS, Fewtrell M, Leonard JV, Bishop NJ (1995) Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 154: 483–487.
Mundy HR, Georgiadou P, Cousins AJ, Davies LC, Leonard JV, Lee PJ (2005) Exercise capacity and biochemical profile during exercise in patients with glycogen storage disease type I. J Clin Endocrinol Metab 90: 2675–2680.
Rake JP, Visser G, Huismans D, et al (2003) Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study. J Inherit Metab Dis 26: 371–384.
Rosenfeld EL, Chibisov IV, Karmansky IM, Tabolin VA, Chistova LV, Leontiev AF (1980) Serum lipoproteins of patients with glycogen storage disease. Clin Chim Acta 102: 99–104.
Schwahn B, Rauch F, Wendel U, Schonau E (2002) Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr 141: 350–356.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Gerard Berry
Competing interests: None declared
References to electronic databases: Glycogen storage disease type III: OMIM 232400. Amylo-1,6-glucosidase: EC 3.2.1.33. Glucose-6-phosphatase: EC 3.1.3.9.
Rights and permissions
About this article
Cite this article
Mundy, H.R., Williams, J.E., Lee, P.J. et al. Reduction in bone mineral density in glycogenosis type III may be due to a mixed muscle and bone deficit. J Inherit Metab Dis 31, 418–423 (2008). https://doi.org/10.1007/s10545-008-0830-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0830-0